High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: Interplay between clinical and animal studies☆
Introduction
Glucocorticoids (GCs) play a major role in orchestrating the complex physiological and behavioral reactions essential for the maintenance of homeostasis (McEwen, 2002). These compounds enable the organism to prepare for, respond to, and cope with the acute demands of physical and emotional stressors. The appropriate GC release, commensurate with stressor severity, enables the body to properly contain stress responses so as to promote recovery by rapidly restoring homeostasis (Yehuda et al., 1998). Indeed, inadequate GC release following stress not only delays recovery by disrupting biological homeostasis in the short run but can also interfere with the processing or interpretation of stressful information that results in long-term disruptions in memory integration (McEwen, 2002). A salient example of such an impaired post-traumatic process in the clinic is exemplified in post-traumatic stress disorder (PTSD) (DSM-IV-TR, American Psychiatric Association, 2000).
While conventional wisdom holds that people who develop PTSD following exposure to extreme trauma might have sustained elevations in GCs, several studies have reported that lower cortisol levels in the acute aftermath of trauma are predictors for subsequent PTSD symptoms (Delahanty et al., 2000, McFarlane et al., 1997, McFarlane, 2000, Witteveen et al., 2010). Therefore, it is possible that the administration of cortisol immediately after exposure to a trauma might alter the trajectory of trauma exposure by promoting recovery. To date, however, information on the effect of cortisol injection on trauma recovery is limited, although a series of naturalistic studies have demonstrated that administration of cortisol following septic shock reduced the incidence of PTSD (Schelling et al., 1999, Schelling et al., 2001, Schelling et al., 2003). Several studies have reported that exogenously administered cortisol reduces PTSD symptoms in patients with chronic PTSD (Aerni et al., 2004, Miller et al., 2011, Suris et al., 2010).
Our group has initiated a series of studies examining the role of GCs in susceptibility to “PTSD-like behaviors” in a well-validated animal model for PTSD (Cohen et al., 2003, Cohen et al., 2005). In keeping with the little data that is available on traumatized people, these studies demonstrated a greater susceptibility to experimentally induced PTSD-like behavioral changes in rats with a hypoactive and hypo-reactive hypothalamic–pituitary–adrenal (HPA) axis, i.e., Lewis strain, compared to a rat strain with a hyper-responsive HPA-axis, i.e., Fischer rats. Exogenous administration of cortisol to Lewis rats prior to the stressor effectively decreased the prevalence of subsequent extreme behavioral disruption (Cohen et al., 2006a). Further animal studies examined the effect of a single intervention with high-dose corticosterone immediately after exposure to a stressor (Cohen et al., 2008b). A controlled prospective study showed a significant reduction in the incidence of PTSD-like behaviors and improved resilience to subsequent trauma (Cohen et al., 2008b). However, corticosterone administration 14 days following stress-exposure and immediately after memory reactivation had no effect on the behavior of the rats (unpublished data). These findings suggest that a disruption in the initial adaptive endogenous response of the HPA-axis unfavorably alters the trajectory of trauma exposure. To the extent that findings from animal models “translate” to humans, treatment with GCs could provide a possible avenue for early pharmacotherapeutic intervention in the acute phase, aimed at prevention of chronic stress-related disorders, such as PTSD.
The goal of this study was twofold: a) to evaluate the therapeutic effects of a single dose of hydrocortisone in acutely traumatized persons, and b) to explore the morphological and molecular changes in brain tissue of animals “treated” with hydrocortisone immediately after exposure to trauma. The first goal was accomplished in the context of a randomized, prospective, double-blind, placebo-controlled trial, and the second, by evaluating dendritic arborization in Golgi-impregnated neurons in dentate gyrus (DG) granule cells of stress-exposed animals and the impact of these changes on the expression of brain-derived neurotrophic factor (BDNF) and postsynaptic density-95 (PSD-95) in this region.
We hypothesized that trauma patients in a hospital emergency room (ER) treated with a single injection of hydrocortisone would have an altered trajectory of PTSD, as measured at one and three months, in a favorable way, as compared to those given a placebo. In parallel, we hypothesized that animals receiving a single high-dose of hydrocortisone immediately after exposure would exhibit increased synaptic plasticity, synaptic strength and dendritic complexity with a concomitant attenuation of behavioral stress responses (less prevalence of PTSD-like response).
Section snippets
Participants
Seventy consecutive patients who were exposed to a traumatic event, experienced either acute stress reaction or sub-threshold acute stress reaction, and met the DSM-IV PTSD A.1 (stressor) and A.2 (response) criteria (fulfilling criteria A, 2 of the symptoms in criteria B, 3 out of 4 of criteria C, D, E, and F, and meeting criterion H of the ASD criteria set out in DSM-IV) were recruited from the emergency department at the Chaim Sheba Medical Center. Exclusion criteria included serious physical
Clinical trial
The hydrocortisone and placebo groups did not differ significantly on any of the demographic measures such as age, gender, marital status, education or on any clinical characteristics (Table 1).
Discussion
The studies described herein provide supportive evidence that the use of high-dose hydrocortisone in trauma care may be protective against the subsequent development of PTSD after traumatic experience. The study highlights two major concepts. The first is that of “golden hours”, i.e. focusing on a defined and limited “window of opportunity”, namely the first 6 hours after the trauma exposure, and the second is secondary prevention via a single high-dose of hydrocortisone, a procedure that aims
Role of the funding source
The National Institute for Psychobiology in Israel, funded by Charles E. Smith Family, The Israel Academy of Science and Humanities (grant #416/09), and the Ministry of Health (grant #3-0000-6086) given to H.C.
Contributors
Joseph Zohar designed the clinical and animal studies, participated in the data analysis and writing of the paper.
Hila Yahalom participated in the clinical study.
Nitsan Kozlovsky participated in the lab and data analysis.
Shlomit Cwikel-Hamzany participated in the clinical study.
Michael Matar participated in the animal study's planning and assisted in the writing of the paper.
Rachel Yehuda designed the clinical study and writing of the paper.
Zeev Kaplan participated in the animal study's
Conflict of interest
There is no conflict of interest for any of the authors.
Acknowledgment
We are grateful for funding from the National Institute for Psychobiology in Israel, funded by Charles E. Smith Family, the Israel Academy of Science and Humanities grant (416/09) and the Ministry of Health (3-0000-6086) grant to H.C.
References (62)
- et al.
The relevance of differential response to trauma in an animal model of post-traumatic stress disorder
Biol. Psychiatry
(2003) - et al.
Unsupervised fuzzy clustering analysis supports behavioral cutoff criteria in an animal model of posttraumatic stress disorder
Biol. Psychiatry
(2005) - et al.
Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats
Biol. Psychiatry
(2006) - et al.
Anisomycin, a protein synthesis inhibitor, disrupts traumatic memory consolidation and attenuates post traumatic stress response in rats
Biol. Psychiatry
(2006) - et al.
Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats
Biol. Psychiatry
(2006) - et al.
Early post-stressor intervention with high dose corticosterone attenuates post traumatic stress response in an animal model of PTSD
Biol. Psychiatry
(2008) - et al.
Early post-stressor intervention with high dose corticosterone attenuates post traumatic stress response in an animal model of PTSD
Biol. Psychiatry
(2008) - et al.
Initial posttraumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims
Biol. Psychiatry
(2000) - et al.
Modification of dendritic development
Prog. Brain Res.
(2002) - et al.
Selective regulation of neurite extension and synapse formation by the beta but not the alpha isoform of CaMKII
Neuron
(2003)
Short-term glucocorticoid manipulations affect neuronal morphology and survival in the adult dentate gyrus
Neuroscience
Exercise can increase small heat shock proteins (sHSP) and pre- and post-synaptic proteins in the hippocampus
Brain Res.
Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparison of stressors
Neuroscience
Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors
Neuroscience
The neurobiology and neuroendocrinology of stress. Implications for post-traumatic stress disorder from a basic science perspective
Psychiatr. Clin. North Am.
Memory-enhancing corticosterone treatment increases amygdala norepinephrine and Arc protein expression in hippocampal synaptic fractions
Neurobiol. Learn. Mem.
Coordinated changes in dendritic arborization and synaptic strength during neural circuit development
Neuron
Morphological development and maturation of granule neuron dendrites in the rat dentate gyrus
Prog. Brain Res.
Exercise-induced changes in dendritic structure and complexity in the adult hippocampal dentate gyrus
Neuroscience
Long-term adrenalectomy causes loss of dentate gyrus and pyramidal neurons in the adult hippocampus
Exp. Neurol.
Effects of stress hormones on traumatic memory formation and the development of posttraumatic stress disorder in critically ill patients
Neurobiol. Learn. Mem.
The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors
Biol. Psychiatry
Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study
Biol. Psychiatry
Regulation of dendritic growth and remodeling by Rho, Rac, and cdc42
Neuron
Associations of cortisol with posttraumatic stress symptoms and negative life events: a study of police officers and firefighters
Psychoneuroendocrinology
Morphological and functional properties of rat dentate granule cells after adrenalectomy
Neuroscience
Phosphatidylinositol 3-kinase activation is required for stress protocol-induced modification of hippocampal synaptic plasticity
J. Biol. Chem.
Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event
Biol. Psychiatry
Low-dose cortisol for symptoms of posttraumatic stress disorder
Am. J. Psychiatry
Dendrite development regulated by CREST, a calcium-regulated transcriptional activator
Science
Corticosterone reduces dendritic complexity in developing hippocampal CA1 neurons
Hippocampus
Cited by (237)
Anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa) via regulating the synaptic plasticity in hippocampus
2024, European Journal of PharmacologyCorticosteroid Treatment During Sepsis Alters Hippocampal Function in Male and Female Survivors
2024, Biological Psychiatry Global Open ScienceGlucocorticoid-based pharmacotherapies preventing PTSD
2023, NeuropharmacologyThe influence of sleep on fear extinction in trauma-related disorders
2023, Neurobiology of StressWhat we know about the role of corticosteroids in psychiatric disorders; evidence from animal and clinical studies
2022, Journal of Psychiatric ResearchAn allostatic epigenetic memory on chromatin footprints after double-hit acute stress
2022, Neurobiology of Stress
- ☆
The trial name: Efficacy of Single Dose IV Hydrocortisone in Post Traumatic Stress Disorder (PTSD) Prevention.
URL: www.clinicaltrials.gov.
Registration number: NCT00855270.